Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress

    NEXT STORY
    Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
    PREV STORY
    OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress

    NEXT STORY
    Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
    PREV STORY
    OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dr. Allen Lichter Joins Cellworks Group Board of Directors

    Former CEO of ASCO Elected to Board of Leading Precision Medicine CompanySAN JOSE, Calif., ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Biocartis Verkrijgt Exclusieve Wereldwijde Licentierechten voor EGFR Ectodomein Mutaties die Respons Voorspellen op Gerichte Behandelingen voor Colorectale (Darm)kanker

    PERSBERICHT: 28 augustus 2018, 07:00 CEST Biocartis Verkrijgt Exclusieve Wereldwijde Licentierechten voor EGFR Ectodomein Mutaties ...

    author_avatar
    NASDAQ Market News

    Summary of Calendar for Upcoming Proposed Delcath Rights Offering

    The Company’s Directors and Officers Indicate Intent to Participate in the Rights Offering Once ...

    author_avatar
    NASDAQ Market News